TCT-160 In-Hospital Switching Of Oral P2Y12 Inhibitor Treatment In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Prevalence, Predictors And Short-Term Outcome

Dimitrios Alexopoulos,Ioanna Xanthopoulou,Spyridon Deftereos,Georgios Sitafidis,Ioannis Kanakakis,Michalis Hamilos,Christos Angelidis,Stylianos Petousis,Dimitrios Stakos,Charalambos Parisis,Manolis Vavuranakis,Periklis Davlouros,John Goudevenos,Christodoulos Stefanadis

American Heart Journal（2013）

引用 70|浏览18

暂无评分

摘要

P2Y12 inhibitor switching has appeared in clinical practice as a consequence of prasugrel and ticagrelor availability, apart from clopidogrel, for use in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). In-hospital P2Y12 inhibitor switching has not

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要